WASHINGTON -- The Neuroguard carotid stent system, with its integrated embolic filter, continued to show good results at 2 ...

The Parkview Heart Institute has been selected by medical technology firm Medtronic as one of 65 hospitals globally to ...

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has received FDA approval to move forward with its Virtue Trial ...

The drug-eluting stent market is anticipated to grow at a CAGR of 8.20% from US$11.499 billion in 2025 to US$17.049 billion ...

Discover how IVBT impacts long-term outcomes in complex in-stent restenosis—read the full report for key clinical insights.

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

If the IVC is patent but severely compressed, a self-expanding stent can be placed in the intrahepatic IVC, followed by a surgical infrahepatic shunt. 47 Mesoatrial shunts have been used when ...

Parkview Health announced today that its Heart Institute has been selected by medical technology firm Medtronic as one of 65 hospitals globally to participate in a clinical trial of a ...

This study was conducted to develop new modified duplex velocity criteria to better define normal carotid (0-< 30%) versus abnormal (≥ 30%) carotid in-stent restenosis. Eighty-three patients who ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

It involves a stent, a spring-like stainless steel device, smaller than a paper clip, being used to hold open a blocked artery. For many people, stenting offers a safe and virtually painless ...

Upon his return in 1986, Dr. Kalarickal performed the country’s first coronary angioplasty. He later also pioneered the use of bio-resorbable stents, which were designed to dissolve naturally in the ...